InvestorsHub Logo
Followers 229
Posts 21458
Boards Moderated 2
Alias Born 08/03/2006

Re: southerngent1 post# 2109

Thursday, 10/19/2017 7:18:12 AM

Thursday, October 19, 2017 7:18:12 AM

Post# of 9819
Awesome. I expect since the price is so out of whack many are ignoring this board and likely the company itself.

Here's what I know...

When a company, especially a start up bio with no revenue, first becomes public they usually have a steady decline until they trigger the interest of the market. Almost regardless of how they plan to save the world it takes time. The market knows they are relying completely on dilution to move forward. The real trick is seeing who is providing their financing. To start it's usually the insiders putting up the biggest chunk. Then, some hyped up retail followers get sucked in. Then, the financing from other entities. This is where we have to be careful. I've seen some really good deals for start ups and some that make me cringe like crazy. Convertibles are our enemy imo. Companies that provide the financing to start ups really could care less in most cases about the company. They just want to be paid back. And the notes always have similar conversion rules with the statement "subject to adjustment as described below". Be aware is all I'm saying.
If the story is good and the company is following through, as frustrating as it may get at times, there's a good chance they can gain enough traction to get better financing. Couple this with revenue that will help circumvent some of the dilution. We're in the stage of diluting to move forward for now imo. So, since inception, one needs to pick where/when they're buying with caution and be very risk aware. If you've done your dd, then you can analyze the potential and measure your risk. I like to use the charts but remember that dilution weighs heavy against the technicals. There are periods when the selling eases, and of course news events, not fluffy press releases but real news. Getting the trial started at Harvard’s Beth Israel Deaconess Medical Center, I think, will be the turning point for OncBiomune. I'm more risk tolerant than many but that's what my money is on for the most part. Bringing in revenue from their product line will take time so will be watching that closely. If they can ebb the tide with that by the end of 2018, awesome.

That's enough from me. Best of luck southerngent!!


This is interesting...

Institutional interest...
GREEN SQUARE CAPITAL LLC 06/30/2017 395,400 130,400 49.21 23
http://www.nasdaq.com/symbol/obmp/institutional-holdings

All imo.

$OBMP

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent THER News